Adaptimmune Therapeutics PLC Increase (Decrease) in Other Operating Assets
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2020-08-06
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for the quarter ending 2020-06-30 was -$874.00K.
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for the quarter ending 2020-03-31 was $259.00K, a 1263.16% increase year-over-year.
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for the quarter ending 2019-12-31 was $2.92M.
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for the quarter ending 2019-09-30 was -$205.00K.
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for fiscal 2019 was $1.45M.
- Adaptimmune Therapeutics PLC increase (decrease) in other operating assets for fiscal 2018 was -$742.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$874.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$615.00K 10-Q · filed 2020-08-06 | $2.30M derived: sum of 3 quarters · filed 2020-08-06 | $2.10M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $259.00K 10-Q · filed 2020-05-14 | $3.18M derived: sum of 2 quarters · filed 2020-05-14 | $2.97M derived: sum of 3 quarters · filed 2020-05-14 | $1.69M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $2.71M derived: sum of 2 quarters · filed 2020-02-27 | $1.43M derived: sum of 3 quarters · filed 2020-08-06 | $1.45M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$1.49M derived: sum of 2 quarters · filed 2020-08-06 | -$1.47M 10-Q · filed 2019-11-06 | -$1.72M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.26M 10-Q · filed 2020-08-06 | -$1.51M derived: sum of 3 quarters · filed 2020-08-06 | -$1.92M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $19.00K 10-Q · filed 2020-05-14 | -$233.00K derived: sum of 2 quarters · filed 2020-05-14 | -$636.00K derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$655.00K derived: sum of 2 quarters · filed 2020-02-27 | -$742.00K 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$490.00K 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | -$87.00K 10-Q · filed 2019-08-01 |